Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Gravas S and Oelke M | Current status of 5alpha-reductase inhibitors in the management of lower urinary tract symptoms and BPH. | 2010 | World J Urol | pmid:19956956 |
Campino C et al. | 11β-Hydroxysteroid dehydrogenase type-2 and type-1 (11β-HSD2 and 11β-HSD1) and 5β-reductase activities in the pathogenia of essential hypertension. | 2010 | Endocrine | pmid:19882252 |
Hong SK et al. | Effect of the dual 5alpha-reductase inhibitor, dutasteride, on serum testosterone and body mass index in men with benign prostatic hyperplasia. | 2010 | BJU Int. | pmid:19793378 |
Hollingsworth JM and Wei JT | Does the combination of an alpha1-adrenergic antagonist with a 5alpha-reductase inhibitor improve urinary symptoms more than either monotherapy? | 2010 | Curr Opin Urol | pmid:19881352 |
Cohen RE and Wade J | Testosterone selectively affects aromatase and 5alpha-reductase activities in the green anole lizard brain. | 2010 | Gen. Comp. Endocrinol. | pmid:19917285 |
Verhovshek T et al. | Testosterone metabolites differentially maintain adult morphology in a sexually dimorphic neuromuscular system. | 2010 | Dev Neurobiol | pmid:20024940 |
UhÃa I et al. | Initial step in the catabolism of cholesterol by Mycobacterium smegmatis mc2 155. | 2011 | Environ. Microbiol. | pmid:21208358 |
Askarova S et al. | Impacts of membrane biophysics in Alzheimer's disease: from amyloid precursor protein processing to aβ Peptide-induced membrane changes. | 2011 | Int J Alzheimers Dis | pmid:21547213 |
Finelli A et al. | Impact of 5α-reductase inhibitors on men followed by active surveillance for prostate cancer. | 2011 | Eur. Urol. | pmid:21211899 |
Jusakul A et al. | Mechanisms of oxysterol-induced carcinogenesis. | 2011 | Lipids Health Dis | pmid:21388551 |